Senior VP, Strategic Solutions and Patient Centricity (Oncology) - Job Opportunity at Ergomed Group

Paris, France
Full-time
Executive
Posted: August 15, 2025
On-site
EUR 280,000 - 350,000 annually plus significant equity participation and performance bonuses. This role commands premium compensation due to the combination of C-suite responsibilities, specialized oncology expertise, and the critical nature of revenue generation in a rapidly expanding organization. The Paris location and international scope justify top-tier European executive compensation.

Benefits

Comprehensive employee visibility with genuine voice in organizational decisions, providing rare C-suite access typically unavailable at larger organizations
Creative contribution opportunities that directly impact strategic direction, offering entrepreneurial freedom within an established framework
Realistic career development pathways with clear progression opportunities in a rapidly expanding organization
International culture exposure across Europe, North America, and Asia, providing global leadership experience
Employee experience prioritization with dedicated focus on well-being and mental health support programs
Work-life balance emphasis as core company value, ensuring sustainable high-performance environment
Training and career development opportunities internally with investment in professional growth
Strong emphasis on personal and professional growth with mentorship programs
Friendly, supportive working environment fostering collaboration and innovation
Opportunity to work with international colleagues globally with English as company language
Access to cutting-edge oncology and rare disease research projects with meaningful patient impact

Key Responsibilities

Drive comprehensive global operational strategy across oncology and rare disease therapeutic areas to maximize revenue generation and enhance market reputation, positioning Ergomed as industry leader
Lead and develop high-performing teams of skilled professionals while fostering collaborative innovation environment that drives competitive advantage
Provide strategic mentorship and guidance to team members, building organizational capability and expertise that supports long-term growth objectives
Leverage deep clinical trial expertise to design strategic plans incorporating sponsor context, therapy characteristics, and regulatory requirements for optimal trial outcomes
Collaborate with internal and external experts to integrate innovative approaches and industry best practices into trial design, maintaining competitive edge
Partner strategically with Business Development to contribute insights during proposal phases, directly impacting new contract acquisition and revenue growth
Develop and present compelling value propositions that differentiate Ergomed's capabilities to prospective clients, driving business development success
Establish Directors of Operational Strategy as Win Strategy owners for key business opportunities, creating systematic approach to competitive positioning
Build and structure Operational and Clinical Intelligence team to deliver value-added outputs that inform strategic decision-making across organization
Establish empirical data access systems focused on target therapeutic areas to leverage intelligence for competitive Win Strategy development
Create Clinician Engagement function to gather KOL insights across geographic regions, informing standard of care understanding and protocol optimization
Champion patient-centric approach across all clinical trial stages, ensuring strategies prioritize patient needs while maintaining operational excellence
Partner with cross-functional teams to predict, identify, and mitigate execution challenges, ensuring successful study delivery and client satisfaction
Represent company at industry meetings and speaking engagements while publishing scientific articles to establish thought leadership
Lead client development, proposal development, and bid defense activities to drive new business acquisition
Establish Ergomed as recognized authority in clinical trial strategy and patient-centricity within pharmaceutical and clinical research landscape

Requirements

Education

Master's degree in relevant scientific, medical, or related field; PhD/MD preferred

Experience

Extensive clinical research experience in oncology with previous CRO environment experience and history of department leadership success

Required Skills

Expertise and extensive clinical research experience in oncology Detailed knowledge of clinical research strategy on a global basis, key stakeholders and KOLs In-depth knowledge of Regulatory Authority regulations Strong understanding and usage of medical terminology Strong business acumen and proven ability to navigate in a complex matrixed global environment Ability to manage multiple tasks to meet deadlines in a dynamic environment Effective organizational, presentation, documentation, and interpersonal skills Strong leadership and communication, verbal, and presentation skills Solutions provider; converts challenges to opportunities Ability to navigate the management matrix; strong people and negotiation skills
Advertisement
Ad Space

Sauge AI Market Intelligence

Industry Trends

The clinical research industry is experiencing unprecedented consolidation with mid-sized CROs like Ergomed positioning themselves as specialized alternatives to large generalist organizations, particularly in high-value therapeutic areas like oncology and rare diseases. This trend creates significant opportunities for senior executives who can drive strategic differentiation and capture market share from both large CROs and smaller boutique firms. Patient-centricity has evolved from a buzzword to a regulatory and commercial imperative, with FDA and EMA increasingly requiring patient-reported outcomes and real-world evidence in clinical trials. Organizations that can demonstrate genuine patient-centric approaches are winning more contracts and achieving faster regulatory approvals, making this expertise highly valuable in executive compensation. The oncology clinical research market is experiencing explosive growth driven by precision medicine, immunotherapy advances, and combination therapy development. The global oncology clinical trials market is projected to reach $15+ billion by 2027, with specialized CROs commanding premium pricing for deep therapeutic expertise and established investigator networks. Rare disease research is becoming increasingly attractive due to regulatory incentives, orphan drug designations, and premium pricing potential. The intersection of oncology and rare diseases represents a highly specialized niche where experienced executives can drive significant value creation through strategic positioning and therapeutic expertise.

Role Significance

This role typically oversees 25-40 professionals across multiple functions including operational strategy, clinical intelligence, and clinician engagement teams. The position involves both direct reports and matrix management of cross-functional stakeholders across global operations, requiring sophisticated leadership and coordination capabilities.
This is a true C-suite executive role with autonomous P&L responsibility and direct impact on organizational strategy and revenue generation. The position bridges operations and commercial functions while maintaining independent authority, indicating significant influence on company direction and shareholder value creation. The global scope and team leadership responsibilities position this role as a potential successor to CEO or COO positions.

Key Projects

Leading strategic positioning initiatives for multi-million dollar contract bids in competitive oncology and rare disease therapeutic areas Developing and implementing patient-centricity frameworks that differentiate Ergomed's service offerings and command premium pricing Building and scaling operational intelligence capabilities that inform win strategies and optimize trial execution across global markets Establishing thought leadership through industry publications, speaking engagements, and KOL relationships that enhance company reputation and competitive positioning

Success Factors

Demonstrated ability to translate deep oncology clinical expertise into competitive business advantage and revenue generation in highly competitive CRO marketplace Exceptional leadership and team-building capabilities to attract, develop, and retain top talent in specialized therapeutic areas where expertise is scarce and highly valued Strategic thinking and execution skills to position mid-sized CRO against both large generalist competitors and smaller specialized firms through differentiated value propositions Strong stakeholder management and communication abilities to influence internal cross-functional teams, external clients, and industry thought leaders across global markets Proven track record of building scalable processes and systems that support rapid organizational growth while maintaining operational excellence and quality standards

Market Demand

Extremely high demand with limited supply of qualified candidates. The intersection of senior CRO leadership experience, oncology specialization, and patient-centricity expertise creates a highly competitive talent market where qualified executives can command premium compensation and equity participation.

Important Skills

Critical Skills

Oncology clinical research expertise is absolutely essential as it forms the foundation of credibility with clients, investigators, and internal teams. Without deep therapeutic knowledge, this executive cannot effectively guide strategic decisions or build relationships with key opinion leaders who drive trial success. Strategic business development and commercial acumen are critical for driving revenue growth and competitive positioning. This role must translate clinical expertise into compelling value propositions that win new business and command premium pricing in competitive markets. Executive leadership and team development capabilities are essential for building and scaling the organization's most strategic capabilities. The ability to attract, develop, and retain specialized talent directly impacts organizational growth and competitive advantage. Global stakeholder management and communication skills are critical for influencing diverse internal and external constituencies across multiple markets, regulatory environments, and cultural contexts.

Beneficial Skills

Advanced degree in oncology or related medical field would enhance credibility with clinical investigators and pharmaceutical clients seeking deep therapeutic expertise Previous pharmaceutical industry experience would provide valuable sponsor perspective and strengthen client relationships through shared understanding of drug development challenges Regulatory affairs expertise would enhance ability to guide strategic decisions and optimize trial designs in complex global regulatory environment Digital health and technology knowledge would support innovation initiatives and enhance competitive positioning as clinical trials become increasingly technology-enabled

Unique Aspects

This role uniquely combines strategic commercial responsibility with operational excellence and patient advocacy, creating a differentiated executive position that spans traditional functional boundaries and provides exceptional learning and growth opportunities
The position offers rare opportunity to shape industry best practices in patient-centricity while building competitive advantage for a rapidly growing specialized CRO in high-value therapeutic areas
The role provides exceptional international exposure and cultural diversity through Ergomed's global operations, offering experiences typically available only at much larger organizations
The combination of autonomy, cross-functional influence, and direct impact on revenue generation creates an entrepreneurial executive opportunity within an established organizational framework

Career Growth

Career progression to CEO/COO roles typically occurs within 3-5 years given the strategic nature of this position and the rapid growth trajectory of specialized CROs. Board positions and advisory roles often develop concurrently with executive responsibilities as industry recognition increases.

Potential Next Roles

Chief Executive Officer or Chief Operating Officer positions at specialized CROs or emerging biotech companies seeking experienced leadership with deep therapeutic expertise Senior executive positions at pharmaceutical companies leading clinical development or strategic partnerships, leveraging CRO experience and industry relationships Board positions or advisory roles with biotech companies, CROs, or healthcare investment firms seeking industry expertise and strategic guidance Entrepreneurial opportunities including founding specialized CROs or consulting firms focused on oncology and rare disease clinical development

Company Overview

Ergomed Group

Ergomed Group represents a compelling mid-market CRO success story, having grown organically and through strategic acquisitions since 1997 to establish strong positions in oncology and rare disease research. The company's focus on employee experience and international culture, combined with specialized therapeutic expertise, positions it as an attractive alternative to large generalist CROs for both talent and clients seeking deep domain knowledge.

Ergomed occupies a strong competitive position in the specialized CRO segment, with its focus on oncology and rare diseases providing defensible market positioning against larger generalist competitors. The company's international presence across Europe, North America, and Asia provides the scale and geographic coverage required for global clinical trials while maintaining the agility and specialization that sponsors value.
The Paris location provides strategic access to European pharmaceutical companies and regulatory agencies while supporting Ergomed's international operations. France's strong life sciences sector and proximity to major European markets make this an ideal location for driving European business development and maintaining relationships with key stakeholders across the region.
Ergomed's emphasis on employee visibility, creative contribution, and work-life balance reflects a mature organizational culture that recognizes the importance of talent retention in specialized markets. The international culture and focus on employee well-being suggest an environment that supports senior executives in driving strategic initiatives while maintaining sustainable high performance.
Advertisement
Ad Space
Apply Now

Data Sources & Analysis Information

Job Listings Data

The job listings displayed on this platform are sourced through BrightData's comprehensive API, ensuring up-to-date and accurate job market information.

Sauge AI Market Intelligence

Our advanced AI system analyzes each job listing to provide valuable insights including:

  • Industry trends and market dynamics
  • Salary estimates and market demand analysis
  • Role significance and career growth potential
  • Critical success factors and key skills
  • Unique aspects of each position

This integration of reliable job data with AI-powered analysis helps provide you with comprehensive insights for making informed career decisions.